首页> 外文期刊>Kidney Cancer Journal >IKCS Recaps Impressive Progress in Ongoing Pivotal Trials and Projects New Directions in Novel Therapeutics
【24h】

IKCS Recaps Impressive Progress in Ongoing Pivotal Trials and Projects New Directions in Novel Therapeutics

机译:IKCS回顾了正在进行的关键试验并取得了令人瞩目的进展,并为新型治疗方法指明了新方向

获取原文
           

摘要

Exciting original research was reported at this year’s 17th International Kidney Cancer Symposium (IKCS) in Miami. With “Emerging Concepts and Therapeutic Tri-als in Progress in RCC” as one of the themes for the sessions, the Symposium provided a dynamic venue and a comprehen-sive agenda for more than 300 attendees at this two-day event, one of two international meetings each year sponsored by the Kidney Cancer Association. From early phase clinical trials of novel therapeutics to updates on pivotal, ongoing studies, the IKCS offered a unique opportunity to gauge progress on a broad spectrum of topics and envision how new information could have translational importance. In this re-port, we will cover a few select presentations of novel data from therapeutic studies that have a potential for becoming practice-changing once fully completed and reported.
机译:在今年第17届迈阿密国际肾脏癌研讨会(IKCS)上报道了令人兴奋的原创研究。本届研讨会以“ RCC中的新兴概念和治疗试验正在进行中”为主题,为两天的活动提供了一个动态的场地和全面的议程,可容纳300多名与会者,这是两个每年由肾脏癌协会主办的国际会议。从新疗法的早期临床试验到关键性正在进行的研究的更新,IKCS提供了一个难得的机会来评估广泛主题的进展并设想新信息如何具有翻译重要性。在本报告中,我们将介绍一些来自治疗研究的新颖数据的精选展示,一旦完全完成并报告,它们就有可能改变实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号